Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2023-03-20 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from PW Medtech Group Limited stating the date of a forthcoming board meeting to approve the annual results for the year ended 31 December 2022 and to consider a final dividend. It does not contain any financial data or the actual annual report but merely announces the meeting date and agenda. The document length is only 1391 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the 'MENU VS MEAL' rule, this is an announcement about the timing of a report and dividend consideration, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2023-03-20 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 28 February 2023. It details movements in authorised/registered share capital, issued shares, share options, and confirmations related to securities issued. The content focuses on share capital changes and confirmations of compliance with listing rules, typical of a regulatory filing related to share capital movements. It is not an annual or interim financial report, earnings release, or management discussion. It is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements. This fits the category of Regulatory Filings (RNS), as it is a compliance document reporting share capital movements and confirmations, not a financial report or announcement of a report.
2023-03-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, and confirmations related to securities issued during the month ended 31 January 2023. The content focuses on share capital changes and confirmations of compliance with listing rules, without financial statements or management discussion. This type of document is a regulatory submission related to share capital movements and compliance confirmations, typical of regulatory filings to the stock exchange. It is not an annual or interim report, earnings release, or other financial report. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (7784 characters) and detailed content support this classification with high confidence.
2023-02-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities for PW Medtech Group Limited, including authorized share capital, issued shares, share options, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and pertains to the month ended 31 December 2022. The content focuses on share capital movements and confirmations rather than financial performance, earnings, or management commentary. It is a regulatory submission related to share capital and securities movements under the Exchange Listing Rules, not an annual or interim financial report, earnings release, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-01-04 English
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO PURCHASE OF MEDICAL DEVICES MOLDS AND COMPONENTS
Regulatory Filings Classification · 95% confidence The document is an announcement regarding continuing connected transactions related to the purchase of medical devices molds and components. It details the framework agreement, parties involved, terms, pricing policy, annual caps, and internal control systems. The document is structured as a formal announcement to shareholders and the public, explaining the nature and implications of the transaction under the Listing Rules. It does not contain financial statements, earnings data, or detailed financial analysis. It is not a full annual or interim report, nor is it a call transcript or management discussion. The content fits the category of a regulatory announcement about connected transactions, which is a common type of regulatory filing in Hong Kong and other markets. Given the detailed nature and regulatory context, but absence of financial data or report content, the best classification is Regulatory Filings (RNS).
2022-12-14 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities for PW Medtech Group Limited, including authorized and issued share capital, share options, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and follows the format of a regulatory return under the Exchange Listing Rules. The content focuses on share capital movements and confirmations rather than financial performance, management changes, or earnings. It is not an announcement of a report but a regulatory filing of share capital movements and confirmations. Therefore, it fits best under Regulatory Filings (RNS).
2022-12-05 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.